Publisher · 2 documents · 17 figures
NMPA (National Medical Products Administration)
17 verified figures from 2 publications by NMPA, a government body. Every figure links to the document and sentence it came from.
Documents used
Every publication we have taken a number from, with the date we read it and the link status at that time.
| Document | Type | Retrieved | Link | Data points |
|---|---|---|---|---|
| Measures facilitate approval of 48 first-in-class innovative drugs Licence: See source | Press release | 17 Sep 2026 | Reachable | 11 |
| China approves 48 innovative drugs in 2024 Licence: See source | Press release | 17 Sep 2026 | Reachable | 6 |
Measures from this publisher
Every measure taken from NMPA, with its latest value and trend. Each value opens its record.
Market size and output 5
Growth and change 1
Other measures 6
12 measures. Each name opens the full series; each value opens the record with its source evidence.
Cite this page
Data on this page is published under CC BY 4.0. Credit National Medical Products Administration as the original publisher; each record page carries its own citation.
National Medical Products Administration. Retrieved from StatOrigin: https://statorigin.org/sources/national-medical-products-administration
Related
Industries using this source
Last verified 27 September 2026. Link status is rechecked weekly.